Unknown

Dataset Information

0

Regulation of cisplatin-resistant head and neck squamous cell carcinoma by the SRC/ETS-1 signaling pathway.


ABSTRACT: BACKGROUND:We investigated the role of the ETS-1 transcription factor in Head and Neck Squamous Cell Carcinoma (HNSCC) in multiple cisplatin-resistant HNSCC cell lines. METHODS:We examined its molecular link with SRC and MEK/ERK pathways and determined the efficacy of either MEK/ERK inhibitor PD0325901 or SRC inhibitor Dasatinib on cisplatin-resistant HNSCC inhibition. RESULTS:We found that ETS-1 protein expression levels in a majority of cisplatin-resistant HNSCC cell types were higher than those in their parental cisplatin sensitive partners. High ETS-1 expression was also found in patient-derived, cisplatin-resistant HNSCC cells. While ETS-1 knockdown inhibited cell proliferation, migration, and invasion, it could still re-sensitize cells to cisplatin treatment. Interestingly, previous studies have shown that MER/ERK pathways could regulate ETS-1 through its phosphorylation at threonine 38 (T38). Although almost all cisplatin-resistant HNSCC cells we tested showed higher ETS-1 phosphorylation levels at T38, we found that inhibition of MEK/ERK pathways with the MEK inhibitor PD0325901 did not block this phosphorylation. In addition, treatment of cisplatin-resistant HNSCC cells with the MEK inhibitor completely blocked ERK phosphorylation but did not re-sensitize cells to cisplatin treatment. Furthermore, we found that, consistent with ETS-1 increase, SRC phosphorylation dramatically increased in cisplatin-resistant HNSCC, and treatment of cells with the SRC inhibitor, Dasatinib, blocked SRC phosphorylation and decreased ETS-1 expression. Importantly, we showed that Dasatinib, as a single agent, significantly suppressed cell proliferation, migration, and invasion, in addition to survival. CONCLUSIONS:Our results demonstrate that the SRC/ETS-1 pathway plays a crucial role and could be a key therapeutic target in cisplatin-resistant HNSCC treatment.

SUBMITTER: Yang Z 

PROVIDER: S-EPMC6532223 | biostudies-literature | 2019 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

Regulation of cisplatin-resistant head and neck squamous cell carcinoma by the SRC/ETS-1 signaling pathway.

Yang Zejia Z   Liao Jipei J   Carter-Cooper Brandon A BA   Lapidus Rena G RG   Cullen Kevin J KJ   Dan Hancai H  

BMC cancer 20190522 1


<h4>Background</h4>We investigated the role of the ETS-1 transcription factor in Head and Neck Squamous Cell Carcinoma (HNSCC) in multiple cisplatin-resistant HNSCC cell lines.<h4>Methods</h4>We examined its molecular link with SRC and MEK/ERK pathways and determined the efficacy of either MEK/ERK inhibitor PD0325901 or SRC inhibitor Dasatinib on cisplatin-resistant HNSCC inhibition.<h4>Results</h4>We found that ETS-1 protein expression levels in a majority of cisplatin-resistant HNSCC cell type  ...[more]

Similar Datasets

| S-EPMC4726344 | biostudies-literature
| S-EPMC7305835 | biostudies-literature
2022-03-01 | PXD001438 | Pride
| S-EPMC5300767 | biostudies-literature
| S-EPMC6385352 | biostudies-literature
| S-EPMC8508472 | biostudies-literature
| S-EPMC6558898 | biostudies-literature
| S-EPMC7944998 | biostudies-literature
| S-EPMC4978947 | biostudies-literature
| S-EPMC10391982 | biostudies-literature